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Methicillin-resistant Staphylococcus aureus (MRSA) has emerged over the past 20 years as 
a cause of infections in community populations, so-called community-associated MRSA 
(CA-MRSA). By pulsed-field gel electrophoresis (PFGE) subtyping, USA300 is the most 
common CA-MRSA strain in the US. It has been suggested that the colonization dynamics 
for CA-MRSA may be different than those for traditional MRSA strains1, with extra-nasal 
colonization potentially playing a role in CA-MRSA transmission and infection1.
Another distinguishing characteristic of USA300 MRSA strains is greater susceptibility to 
non-β-lactam antibiotics compared to healthcare-associated MRSA strains. However, multi-
drug resistant (MDR) USA300 strains have been described, largely among HIV-infected 
patients and men who have sex with men (MSM)2. Also of concern, resistance to common 
decolonizing agents such as mupirocin2 and chlorhexidine gluconate (CHG)3 has been 
reported in CA-MRSA.
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The objectives of this study were to examine the phenotype of USA300 MRSA strains, the 
prevalence of the qacA/B gene in this population, and the anatomic sites of colonization by 
PFGE pattern.
We previously reported on the prevalence of nasal and extra-nasal CA-MRSA colonization 
among inpatients (374 HIV-infected and 371 HIV-negative) at Stroger Hospital of Cook 
County (CCH), the major safety-net hospital in Chicago, IL4. As described elsewhere, nasal 
and extra-nasal (throat, axilla, inguinal, peri-rectal, and chronic wound if present) 
surveillance swab specimens were collected from patients within 72 hours of admission 
from March 2011-April 2012; cultures were processed with broth enrichment4. Gender was 
recorded and enrolled men were asked if they identified themselves as MSM. Genotypic 
analysis with PFGE was performed on all identified MRSA isolates. Results were 
interpreted as described by McDougal, et al5.
Confirmed MRSA isolates had antibiotic susceptibility determined (MicroScan Walkaway 
System, Siemens Healthcare Diagnostics, West Sacramento, CA). For USA300 MRSA 
strains, MDR was defined as resistance to four or more non-β lactam antibiotic classes. 
High-level mupirocin resistance was assessed using disk diffusion6.
Carriage of qacA and qacB genes, which code for efflux pumps associated with increased 
minimum inhibitory concentrations (MICs) of CHG7, was assessed using real-time PCR as 
described previously8.
Chi-square analysis was used to examine the association of PFGE patterns and colonization 
sites, with Fisher’s exact test used for small samples. SAS software version 9.2 (SAS 
Institute, Cary, NC) was used for statistical analysis. The study was approved by the 
Institutional Review Board of CCH and Rush University Medical Center.
We observed that following the nares, the peri-rectal area was the second most common site 
of colonization (58% of colonized individuals). Prevalence of extra-nasal and exclusive 
extra-nasal colonization was not significantly different between patients colonized with 
USA300 or non-USA300 strains (Table 1). However, the average number of sites colonized 
was significantly higher for USA300 versus non-USA300 strains [2.8 (SD 1.51) and 2.2 
(1.48), respectively, p=0.049]. Inguinal, peri-rectal, and concomitant inguinal and peri-rectal 
colonization were all significantly associated with colonization with the USA300 strain type 
in comparison to non-USA300 MRSA strains (Table 1). Inguinal or peri-rectal MRSA 
colonization was found more often in men (63/480; 13%)—MSM (OR=2.2; 95% CI, 1.1, 
4.2; p=0.02) and heterosexual men (OR=1.8; 95% CI, 1.02, 3.2; p=.04)—than in women 
(20/265; 8%), OR=1.9 (95% CI, 1.1, 3.1), p=0.02.
There were 5 individuals who had a MRSA infection at the time of enrollment and they 
were all found to have colonization with MRSA. Four of these individuals had SSTIs and 
were colonized with the USA300 strain type and one individual had a bloodstream infection 
and was colonized with a non-USA300 strain type. Excluding chronic wound cultures, each 
of these individuals had 3–5 sites of MRSA colonization, suggesting a significant level of 
extra-nasal colonization and colonization burden for individuals infected with MRSA.
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3.4% of colonized individuals carried high-level mupirocin-resistant strains (1 USA100, 2 
USA500, 1 USA300). Of the individuals colonized with USA300 MRSA strains, 4 (5%) 
carried MDR strains. There were 117 MRSA isolates evaluated for the presence of the 
qacA/B genes; all were negative.
We examined colonization and molecular characteristics of CA-MRSA isolates collected 
from patients seeking care at the major safety-net hospital in Chicago. We found that 
inguinal and peri-rectal colonization was more common with the USA300 strain type than 
with non-USA300 MRSA strains. In addition, highly antibiotic resistant USA300 MRSA 
strains were rare and none of the MRSA isolates collected over a 14 month study period was 
found to harbor the qacA/B genes.
We observed that males—both heterosexual males and MSM—had a higher prevalence of 
inguinal and peri-rectal MRSA colonization in comparison to females. Similarities observed 
in colonization patterns between MSM and heterosexual males suggest that perhaps social, 
hormonal, skin biology, or genetic differences between genders play a role in colonization 
dynamics rather than sexual orientation9.
The absence of qacA/B genes among MRSA isolates in the population we studied is 
consistent with other reports in the US10. In contrast to reports in San Francisco2, MDR 
USA300 strains were relatively rare in our population, which comprised a diverse group of 
HIV-infected and HIV-negative individuals. However, continued surveillance of antibiotic 
resistance patterns is needed to understand the evolving epidemiology of USA300 strains as 
well as to inform empiric therapeutic decisions.
Our study is limited in that we did not assess frequency of mupirocin or CHG use in our 
population, although CCH does not have mupirocin on its antibiotic formulary and CHG 
bathing use has been limited to ICU and pre-operative patients. In addition, we relied on 
self-report of MSM status which could lead to recall bias. Finally, we performed PFGE on 
one MRSA colony morphotype per body site and therefore may have failed to detect 
coexistent minority subpopulations.
In summary, our study highlights that inguinal and peri-rectal colonization appears to be 
more frequent with the USA300 strain type and that gender may play a role in location of 
extra-nasal CA-MRSA colonization. Patients with clinical MRSA infections appeared to be 
those with more sites of MRSA colonization. Although mupirocin resistance and presence of 
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Table 1
Association of Pattern of Anatomic Site of Colonization and Pulsed-Field Gel Electrophoresis Profile among 
Individuals Colonized with Community-Associated Methicillin-Resistant Staphylococcus aureus
USA300a(n=79) non-USA300 (n=36) OR (95% CI) p value
Anatomic Site of Colonization
 Anterior nares 50 (63%) 21 (58%) -- 0.61
 Throat 35 (44%) 16 (44%) -- 0.99
 Axilla 31 (39%) 12 (33%) -- 0.54
 Inguinal 49 (62%) 15 (42%) 2.3 (1.02, 5.11) 0.04
 Peri-rectal 52 (66%) 15 (42%) 2.7 (1.2, 6.06) 0.015
 Inguinal and peri-rectal region 40 (51%) 9 (25%) 3.1 (1.28, 7.37) 0.01
 Wound 6 (8%) 1 (3%) -- 0.43
 Extra-nasal colonization 74 (94%) 32 (89%) -- 0.46
 Exclusive extra-nasal colonization 29 (37%) 15 (42%) -- 0.61
 Average number of sites colonized (SD) 2.8 (1.51) 2.2 (1.48) -- 0.049
Data are No. (%) of patients, unless otherwise indicated.
NOTE. Any extra-nasal colonization was defined as the presence of CA-MRSA extra-nasal colonization irrespective of anterior nares culture 
results. Exclusive extra-nasal colonization was defined as CA-MRSA colonization at extra-nasal sites and negative anterior nares cultures for CA-
MRSA.
a
Two individuals were colonized with both USA300 and non-USA300 strains and were excluded from the comparison of USA300 to non-USA300 
strains. Therefore, the total number of patients used in the analysis was 115.
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